ABATACEPT BELATACEPT ANALOG THERAPEUTIC APPROACH

The emerging therapeutic combination of abatacept, a T-cell modulator, and a CTLA4 immunoglobulin (CTLA4lg) represents a exciting strategy for addressing inflammatory conditions. This distinct method seeks to augment immune tolerance by inhibiting co-stimulatory interactions vital for T-cell prol